These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rare mutations of p53, Ki-ras, and beta-catenin genes and absence of K-sam and c-erbB-2 amplification in N-methyl-N'-nitro-N-nitrosoguanidine-induced rat stomach cancers. Hirayama Y; Wakazono K; Yamamoto M; Kitano M; Tatematsu M; Nagao M; Sugimura T; Ushijima T Mol Carcinog; 1999 May; 25(1):42-7. PubMed ID: 10331743 [TBL] [Abstract][Full Text] [Related]
4. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization. Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658 [TBL] [Abstract][Full Text] [Related]
5. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers. Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219 [TBL] [Abstract][Full Text] [Related]
6. Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers. Simms LA; Zou TT; Young J; Shi YQ; Lei J; Appel R; Rhyu MG; Sugimura H; Chenevix-Trench G; Souza RF; Meltzer SJ; Leggett BA Oncogene; 1997 May; 14(21):2613-8. PubMed ID: 9191061 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of genetic disorders of cancer of the rectum: differences in relation to cancer of the colon]. Rebischung C; Laurent-Puig P; Gerard JP; Thomas G; Hamelin R Gastroenterol Clin Biol; 1998; 22(8-9):679-87. PubMed ID: 9823556 [TBL] [Abstract][Full Text] [Related]
8. Amplified genes in cancer in upper digestive tract. Yoshida T; Sakamoto H; Terada M Semin Cancer Biol; 1993 Feb; 4(1):33-40. PubMed ID: 8095412 [TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms of carcinogenesis in human stomach cancer: K-sam gene]. Yoshida K; Toge T; Kuniyasu H; Yasui W; Tahara E Nihon Rinsho; 2001 Apr; 59 Suppl 4():53-9. PubMed ID: 11424439 [No Abstract] [Full Text] [Related]
10. [New molecular prognostic markers in gastric carcinoma]. Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902 [TBL] [Abstract][Full Text] [Related]
11. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Jang JH; Shin KH; Park JG Cancer Res; 2001 May; 61(9):3541-3. PubMed ID: 11325814 [TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553 [TBL] [Abstract][Full Text] [Related]
13. Genetic pathways of two types of gastric cancer. Tahara E IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss at 10q26 in osteosarcoma in the region of the BUB3 and FGFR2 genes. Mendoza S; David H; Gaylord GM; Miller CW Cancer Genet Cytogenet; 2005 Apr; 158(2):142-7. PubMed ID: 15796961 [TBL] [Abstract][Full Text] [Related]
15. [Correlation of multiple gene changes with malignant phenotype of human gastric carcinoma]. Gao C; Lu Y Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):671-5. PubMed ID: 9275549 [TBL] [Abstract][Full Text] [Related]